A stock’s 52-week high and low prices can offer a wealth of information about its current standing and prospective future performance. Akero Therapeutics Inc.’s current trading price is -13.09% away from its 52-week high, while its distance from the 52-week low is 101.27%. The stock’s price range for this time frame has been between $25.21 and $58.38. The trading volume of the company’s shares in the Healthcare reached around 1.85 million for the day, which was evidently higher than the average daily volume of 0.69 million over the last three months.
Akero Therapeutics Inc. (AKRO) current stock price is $50.74. During the last trading session, the stock soared, reaching $51.695 after opening at $50.66. The stock’s lowest point was $50.165 before it closed at $50.33.
The stock market performance of Akero Therapeutics Inc. has been very steady. Over the last year, the company’s stock hit its highest at $58.38 on 06/13/23, while the lowest price during the same time frame was $25.21, recorded on 09/23/22.
How Financial Performance Impacts Market Capitalization
Akero Therapeutics Inc. (AKRO) has experienced a quarterly decline of -8.03% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 2.90B and boasts a workforce of 44 employees.
The Role of Moving Averages and Trading Volume in Technical Analysis
Based on Barchart.com data, the company’s moving average over the 100-day period was 46.90, with a change in price of +4.44. Similarly, Akero Therapeutics Inc. recorded 673,731 in trading volume during the last 100 days, posting a change of +9.59%.
How AKRO’s Debt-to-Equity Ratio Affects Financial Health
A company’s financial condition and market reputation can be evaluated using the debt-to-equity (D/E) ratio. This ratio, calculated by dividing a company’s total liabilities by its shareholders’ equity, indicates the proportion of debt a company employs to back its assets in relation to its shareholders’ equity. At the time of writing, the total D/E ratio for AKRO stands at 0.04. Similarly, the long-term debt-to-equity ratio is also 0.04.
AKRO Stock Stochastic Average
Akero Therapeutics Inc.’s raw stochastic average for the past 50 days is currently at 82.47%. This represents a surge from the raw stochastic average of the last 20 days, which was recorded at 74.07%. Additionally, the company’s Stochastic %K and %D values for the past 20 days were 69.03% and 62.83%, respectively.
AKRO Stock Price Performance Analysis
The stock price performance for the year has been a mixed bag, indicating either a pessimistic or optimistic outlook depending on how you look at it. Until today this year the stock’s price performance recorded a decrease of -7.41%. However, over the last six months, the performance has been weaker by 25.25%. The price of AKRO increased 6.89% over the last 30 days. And in the last five days, it has surged by 1.87%.